IGAM
ZBIO

iA Global Asset Management’s Zenas BioPharma ZBIO Stock Holding History

iA Global Asset Management’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.22M Buy
+215,830
New +$4.84M 0.06% 205

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

iA Global Asset Management's ZBIO Position: Q1 2026 in Review

iA Global Asset Management opened a new position in Zenas BioPharma (ZBIO) in Q1 2026: 215,830 shares worth $4.22M. The stake represents 0.06% of the portfolio and ranks #205 among its holdings.

139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • iA Global Asset Management held 215,830 shares of Zenas BioPharma worth $4.22M as of Q1 2026.
  • Zenas BioPharma was a new iA Global Asset Management position in Q1 2026.
  • Zenas BioPharma made up 0.06% of iA Global Asset Management's portfolio in Q1 2026, its #205 holding.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.